Invention Grant
- Patent Title: Engineered nucleic acids and methods of use thereof
-
Application No.: US15981762Application Date: 2018-05-16
-
Publication No.: US10751386B2Publication Date: 2020-08-25
- Inventor: Stephane Bancel , Jason P. Schrum , Alexander Aristarkhov
- Applicant: ModernaTX, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ModernaTX, Inc.
- Current Assignee: ModernaTX, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K49/00
- IPC: A61K49/00 ; A61K39/00 ; A61K39/38 ; A61K38/17 ; C07K14/47 ; A61K45/06 ; A61K38/46 ; A61K48/00
Abstract:
Provided are compositions and methods for delivering biological moieties such as modified nucleic acids into cells to kill or reduce the growth of microorganisms. Such compositions and methods include the use of modified messenger RNAs, and are useful to treat or prevent microbial infection, or to improve a subject's heath or wellbeing.
Public/Granted literature
- US20180271938A1 ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF Public/Granted day:2018-09-27
Information query
